{
  "Variants Include": [
    {
      "Gene": "LAMA2",
      "variants": [
        {
          "HGVS": "NM_001172429.2:c.1234A>G",
          "cDNA Change": {
            "transcript": "NM_001172429.2",
            "ref": "A",
            "alt": "G",
            "position": "1234"
          },
          "Protein Change": {
            "ref": "M",
            "alt": "G",
            "position": "412"
          },
          "Description in input context": "c.1234A>G (p.Met412Gly)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Limb-girdle muscular dystrophy 2A",
    "MONDO": "MONDO:0004886"
  },
  "Experiment Method": [
    {
      "Assay Method": "qRT-PCR and Immunofluorescence Analysis",
      "Material used": {
        "Material Source": "Patient-Derived Material",
        "Material Name": "Fibroblasts",
        "Description": "Experiments were performed using fibroblasts obtained from patients with Limb-girdle muscular dystrophy 2A."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001172429.2:c.1234A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "likely pathogenic",
          "Result Description": "qRT-PCR showed a 30% reduction in LAMA2 mRNA expression for the variant NM_001172429.2:c.1234A>G compared to wild-type controls. Immunofluorescence analysis showed a corresponding reduction in LAMA2 protein expression."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed per condition."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Technical replicate details were not specified in the provided scenario."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type fibroblasts were used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Negative control wells without cDNA were included."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D. - Statistical methods were not specified."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "100% of wild type expression level.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Less than 60% of wild type expression level.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}